Literature DB >> 16522674

The perception of rheumatoid arthritis core set measures by rheumatologists. Results of a survey.

D Aletaha1, K P Machold, V P K Nell, J S Smolen.   

Abstract

OBJECTIVE: To investigate the perception of values of individual core set measures by rheumatologists, and how it differs across measures and across physicians.
METHODS: We designed a survey in which 44 international expert rheumatologists explicitly marked positions on the scales of seven core-set measures that in their opinion corresponded to cut-points between remission, low, moderate and high disease activity. The measures comprised swollen and tender joint counts (SJC, TJC), CRP, ESR, patient and evaluator global assessments of activity (PGA, EGA), and the Health Assessment Questionnaire Disability Index (HAQ).
RESULTS: The interpretation of measures across physicians was most consistent for ESR and PGA, while for CRP and joint counts there was most variation. Joint counts and CRP implied active disease at lower relative values (using normalized scales) than did PGA, EGA or ESR (P < 0.01 for most comparisons; Bonferroni-adjusted Wilcoxon signed rank test), and most physicians tended to tolerate higher numbers of tender joints than swollen joints to define similar levels of disease activity. Given these cut-points, more RA patients in a typical cross-sectional cohort would be regarded as being in remission according to joint counts (SJC, 35%; TJC, 55%) than to global scores (PGA, 18%; EGA, 9%), and fewer patients would be regarded as being in remission by physician-derived or laboratory measures than by patient-derived ones.
CONCLUSION: These data give insights into the integrative process of activity evaluation and will be informative for future survey designs, studies using physician opinion as the gold standard for criterion validity of disease activity, and allow 'activity mapping' of values on different scales based on expert opinion.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16522674     DOI: 10.1093/rheumatology/kel074

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  11 in total

1.  Potential of the HAQ score as clinical indicator suggesting comprehensive multidisciplinary assessments: the Swedish TIRA cohort 8 years after diagnosis of RA.

Authors:  Ingrid Thyberg; Ö Dahlström; M Björk; P Arvidsson; M Thyberg
Journal:  Clin Rheumatol       Date:  2012-01-17       Impact factor: 2.980

2.  Foot pain in rheumatoid arthritis prevalence, risk factors and management: an epidemiological study.

Authors:  Simon J Otter; Kevin Lucas; Kate Springett; Ann Moore; Kevin Davies; Liz Cheek; Adam Young; Karen Walker-Bone
Journal:  Clin Rheumatol       Date:  2009-12-08       Impact factor: 2.980

Review 3.  PROMs in inflammatory arthritis: moving from static to dynamic.

Authors:  Yasser El Miedany
Journal:  Clin Rheumatol       Date:  2013-04-10       Impact factor: 2.980

4.  Treating rheumatoid arthritis to target: recommendations of an international task force.

Authors:  Josef S Smolen; Daniel Aletaha; Johannes W J Bijlsma; Ferdinand C Breedveld; Dimitrios Boumpas; Gerd Burmester; Bernard Combe; Maurizio Cutolo; Maarten de Wit; Maxime Dougados; Paul Emery; Alan Gibofsky; Juan Jesus Gomez-Reino; Boulos Haraoui; Joachim Kalden; Edward C Keystone; Tore K Kvien; Iain McInnes; Emilio Martin-Mola; Carlomaurizio Montecucco; Monika Schoels; Désirée van der Heijde; Desirée van der Heijde
Journal:  Ann Rheum Dis       Date:  2010-03-09       Impact factor: 19.103

Review 5.  Patient global assessment in measuring disease activity in rheumatoid arthritis: a review of the literature.

Authors:  Elena Nikiphorou; Helga Radner; Katerina Chatzidionysiou; Carole Desthieux; Codruta Zabalan; Yvonne van Eijk-Hustings; William G Dixon; Kimme L Hyrich; Johan Askling; Laure Gossec
Journal:  Arthritis Res Ther       Date:  2016-10-28       Impact factor: 5.156

6.  Common Evaluations of Disease Activity in Rheumatoid Arthritis Reach Discordant Classifications across Different Populations.

Authors:  Helena Canhão; Ana Maria Rodrigues; Maria João Gregório; Sara S Dias; José António Melo Gomes; Maria José Santos; Augusto Faustino; José António Costa; Cornelia Allaart; Emilia Gvozdenović; Desirée van der Heijde; Pedro Machado; Jaime C Branco; João Eurico Fonseca; José António Silva
Journal:  Front Med (Lausanne)       Date:  2018-03-08

Review 7.  Developments in the clinical understanding of rheumatoid arthritis.

Authors:  Josef S Smolen; Daniel Aletaha
Journal:  Arthritis Res Ther       Date:  2009-01-30       Impact factor: 5.156

8.  Focus group interviews reveal reasons for differences in the perception of disease activity in rheumatoid arthritis.

Authors:  Margot J M Walter; Adriaan Van't Spijker; Annelieke Pasma; Johanna M W Hazes; Jolanda J Luime
Journal:  Qual Life Res       Date:  2016-07-21       Impact factor: 4.147

9.  Evaluation of newly proposed remission cut-points for disease activity score in 28 joints (DAS28) in rheumatoid arthritis patients upon IL-6 pathway inhibition.

Authors:  M Schoels; F Alasti; J S Smolen; D Aletaha
Journal:  Arthritis Res Ther       Date:  2017-07-04       Impact factor: 5.156

10.  Minimal disease activity is a stable measure of therapeutic response in psoriatic arthritis patients receiving treatment with adalimumab.

Authors:  Frank Behrens; Michaela Koehm; Eva C Schwaneck; Marc Schmalzing; Holger Gnann; Gerd Greger; Hans-Peter Tony; Harald Burkhardt
Journal:  Rheumatology (Oxford)       Date:  2018-11-01       Impact factor: 7.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.